MedPath

MACUGEN

MACUGEN

Discontinued
DIN Number

02267225

Drug Class

Human

Market Date

Aug 26, 2005

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02267225
AIG Number0150901001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01LA03 PEGAPTANIB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravitreal
AHFS Classification52:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

PEGAPTANIBActive
Strength: 0.3 MG / 90 MCL
Monograph: PEGAPTANIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.